**Recent legislative action centered on the One Big Beautiful Bill Act (OBBBA), signed in July 2025, which permanently extended most 2017 TCJA business provisions—including full expensing, domestic R&D deductibility, and modified international rules—while preserving the 21% corporate rate.** No subsequent measures have advanced a further statutory rate reduction. With the November 2026 midterms approaching, congressional attention has shifted to appropriations, defense authorization, and other year-end priorities during the lame-duck period. Limited floor time and the absence of active reconciliation instructions targeting corporate rates constrain prospects for new rate legislation before 2027. Corporate receipts have declined due to OBBBA incentives, but this reflects existing policy rather than new rate cuts. Traders view the compressed timeline and crowded agenda as significant barriers to enactment.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว$16,849 ปริมาณ
$16,849 ปริมาณ
$16,849 ปริมาณ
$16,849 ปริมาณ
Note that the cut does not need to go into effect before the resolution date - it just needs to be signed into law by then.
This market's primary resolution source will be official information from the Trump administration, however a consensus of credible information will also be used.
ตลาดเปิดเมื่อ: Nov 5, 2025, 1:03 PM ET
ผู้ตัดสินผล
0x65070BE91...Note that the cut does not need to go into effect before the resolution date - it just needs to be signed into law by then.
This market's primary resolution source will be official information from the Trump administration, however a consensus of credible information will also be used.
ผู้ตัดสินผล
0x65070BE91...**Recent legislative action centered on the One Big Beautiful Bill Act (OBBBA), signed in July 2025, which permanently extended most 2017 TCJA business provisions—including full expensing, domestic R&D deductibility, and modified international rules—while preserving the 21% corporate rate.** No subsequent measures have advanced a further statutory rate reduction. With the November 2026 midterms approaching, congressional attention has shifted to appropriations, defense authorization, and other year-end priorities during the lame-duck period. Limited floor time and the absence of active reconciliation instructions targeting corporate rates constrain prospects for new rate legislation before 2027. Corporate receipts have declined due to OBBBA incentives, but this reflects existing policy rather than new rate cuts. Traders view the compressed timeline and crowded agenda as significant barriers to enactment.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว



ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย